ACLAX | VMVAX | ACLAX / VMVAX | |
Total Expense Ratio | 1.23 | 0.07 | 1,757% |
Annual Report Gross Expense Ratio | 1.23 | 0.07 | 1,757% |
Fund Existence | 20 years | 14 years | - |
Gain YTD | 4.871 | 3.573 | 136% |
Front Load | 6% | N/A | - |
Min. Initial Investment | 2500 | 3000 | 83% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 7.05B | 29.9B | 24% |
Annual Yield % from dividends | 1.32 | 2.26 | 59% |
Returns for 1 year | 5.83 | 12.14 | 48% |
Returns for 3 years | 7.90 | 28.52 | 28% |
Returns for 5 years | 21.75 | 77.08 | 28% |
Returns for 10 years | 10.50 | 88.11 | 12% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
PFF | 31.01 | 0.34 | +1.11% |
iShares Preferred&Income Securities ETF | |||
FMET | 34.13 | 0.22 | +0.65% |
Fidelity Metaverse ETF | |||
BUFF | 47.24 | 0.22 | +0.47% |
Innovator Laddered Allc Pwr Bfr ETF™ | |||
BSL | 14.29 | 0.01 | +0.07% |
Blackstone Senior Floating Rate 2027 Term Fund | |||
LFAI | 125.51 | N/A | N/A |
LifeX 2050 Longevity Income ETF |